Cargando…

Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia

BACKGROUND: Although the mononuclear cell (MNC) transplantation could theoretically induce therapeutic angiogenesis in the patients with no-option critical limb ischemia (NO-CLI), the clinical responses to this approach are inconsistent among different clinical trials. The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Tianyue, Liu, Hao, Fang, Yuan, Wei, Zheng, Gu, Shiyang, Fang, Gang, Liu, Yifan, Luo, Yang, Guo, Daqiao, Xu, Xin, Chen, Bin, Jiang, Junhao, Yang, Jue, Shi, Zhenyu, Zhu, Ting, Shi, Yun, Liu, Peng, Dong, Zhihui, Fu, Weiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329149/ https://www.ncbi.nlm.nih.gov/pubmed/30635050 http://dx.doi.org/10.1186/s13287-018-1117-5

Ejemplares similares

A Five‐Year Study of the Efficacy of Purified CD34+ Cell Therapy for Angiitis‐Induced No‐Option Critical Limb Ischemia
por: Fang, Yuan, et al.
Publicado: (2018)

Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia
por: Jiang, Xiaolang, et al.
Publicado: (2021)

Purified CD34(+) cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial
por: Dong, Zhihui, et al.
Publicado: (2018)

Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience
por: Fang, Gang, et al.
Publicado: (2020)

Autologous Stem Cells Transplantation for No-Option Angiitis-Induced Critical Limb Ischemia: Recurrence and New Lesion
por: Liu, Hao, et al.
Publicado: (2022)

Three‐year outcomes of peripheral blood mononuclear cells vs purified CD34 (+) cells in the treatment of angiitis‐induced no‐option critical limb ischemia and a cost‐effectiveness assessment: A randomized single‐blinded noninferiority trial
por: Liu, Hao, et al.
Publicado: (2021)

The peripheral blood mononuclear cells versus purified CD34(+) cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis—a randomized single-blinded non-inferiority trial
por: Liu, Hao, et al.
Publicado: (2022)

Bmal1 Downregulation Worsens Critical Limb Ischemia by Promoting Inflammation and Impairing Angiogenesis
por: Xu, Lirong, et al.
Publicado: (2021)

Return to work after cell transplantation in patients with angiitis-induced critical limb ischaemia and factors related: a single-centre retrospective cohort study
por: Liu, Hao, et al.
Publicado: (2022)

Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia
por: Yanishi, Kenji, et al.
Publicado: (2020)

Prediction of 2-Year Major Adverse Limb Event-Free Survival After Percutaneous Transluminal Angioplasty and Stenting for Lower Limb Atherosclerosis Obliterans: A Machine Learning-Based Study
por: Pan, Tianyue, et al.
Publicado: (2022)

Autologous Peripheral Blood Mononuclear Cells for Limb Salvage in Diabetic Foot Patients with No-Option Critical Limb Ischemia
por: Scatena, Alessia, et al.
Publicado: (2021)

Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia
por: Madaric, Juraj, et al.
Publicado: (2016)

A balloon-supported embolism protection technique during vertebral/subclavian artery angioplasty stenting
por: Liu, Hao, et al.
Publicado: (2022)

Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells
por: Altaner, Cestmir, et al.
Publicado: (2013)

Oroxylin a Attenuates Limb Ischemia by Promoting Angiogenesis via Modulation of Endothelial Cell Migration
por: Zhang, Lusha, et al.
Publicado: (2021)

Exosomal Transfer of miR-185 Is Controlled by hnRNPA2B1 and Impairs Re-endothelialization After Vascular Injury
por: Si, Yi, et al.
Publicado: (2021)

Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived regenerative cells: TACT-ADRC multicenter trial
por: Shimizu, Yuuki, et al.
Publicado: (2022)

Predictors and Treatments of Proglide-Related Complications in Percutaneous Endovascular Aortic Repair
por: Hu, Guohua, et al.
Publicado: (2015)

The promotion action of AURKA on post-ischemic angiogenesis in diabetes-related limb ischemia
por: Bai, Tao, et al.
Publicado: (2023)

Stakeholder Values and Preferences in Lower Limb Amputation for No-Option Chronic Limb Threatening Ischemia
por: Nieuwstraten, Jelle A, et al.
Publicado: (2021)

Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial
por: Jiang, Xiaolang, et al.
Publicado: (2022)

Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers
por: Panunzi, Andrea, et al.
Publicado: (2022)

LOX-1 Plays an Important Role in Ischemia-Induced Angiogenesis of Limbs
por: Shiraki, Takeru, et al.
Publicado: (2014)

SUV39H1 Inhibits Angiogenesis in Limb Ischemia of Mice
por: Niu, Wenhao, et al.
Publicado: (2023)

Exercise and Ischemia-Activated Pathways in Limb Muscle Angiogenesis and Vascular Regeneration
por: Narkar, Vihang A.
Publicado: (2023)

Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model
por: van Rhijn-Brouwer, Femke Christina Ching-Chuan, et al.
Publicado: (2022)

Optical coherence tomography angiography for noninvasive evaluation of angiogenesis in a limb ischemia mouse model
por: Wang, Liwei, et al.
Publicado: (2019)

Limb salvage in diabetic patients with no-option critical limb ischemia: outcomes of a specialized center experience
por: Dalla Paola, Luca, et al.
Publicado: (2019)

A biomaterial-based therapy for lower limb ischemia using Sr/Si bioactive hydrogel that inhibits skeletal muscle necrosis and enhances angiogenesis
por: Yuan, Ye, et al.
Publicado: (2023)

Protective Role of Sulodexide on Renal Injury Induced by Limb Ischemia-Reperfusion
por: Yuan, Tao, et al.
Publicado: (2021)

Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent
por: Sanada, Fumihiro, et al.
Publicado: (2014)

EZH2 Modulates Angiogenesis In Vitro and in a Mouse Model of Limb Ischemia
por: Mitić, Tijana, et al.
Publicado: (2015)

Treatment with Sildenafil and Donepezil Improves Angiogenesis in Experimentally Induced Critical Limb Ischemia
por: Constantinescu, Ioana M., et al.
Publicado: (2017)

Adverse Effect of Circadian Rhythm Disorder on Reparative Angiogenesis in Hind Limb Ischemia
por: Tsuzuki, Kazuhito, et al.
Publicado: (2021)

Evaluation of post-natal angiogenesis in a mouse hind limb ischemia model
por: Recatalá, Cristina Arce, et al.
Publicado: (2023)

Characteristics and Outcome for Persons with Diabetic Foot Ulcer and No-Option Critical Limb Ischemia
por: Meloni, Marco, et al.
Publicado: (2020)

Cellular therapies in no-option critical limb ischemia: present status and future directions
por: Kwiatkowski, Tomasz, et al.
Publicado: (2022)

Peripheral Blood Mononuclear Cells: A New Frontier in the Management of Patients with Diabetes and No-Option Critical Limb Ischaemia
por: Meloni, Marco, et al.
Publicado: (2023)

Angiogenic Factor AGGF1 Promotes Therapeutic Angiogenesis in a Mouse Limb Ischemia Model
por: Lu, Qiulun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_peigqjk60v3qlispuh5omohiri